Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Dnase1l2em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Dnase1l2em1/Cya

Common Name
Dnase1l2-KO
Product ID
S-KO-11870
Backgroud
C57BL/6JCya
Strain ID
KOCMP-66705-Dnase1l2-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Dnase1l2-KO Mouse (Catalog S-KO-11870) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Dnase1l2-KO
Strain ID
KOCMP-66705-Dnase1l2-B6J-VA
Gene Name
Dnase1l2
Product ID
S-KO-11870
Gene Alias
4733401H14Rik
Background
C57BL/6JCya
Gene Full Name
deoxyribonuclease 1-like 2
Modification
Conventional knockout
NCBI ID
66705 (Mouse)
Phenotype
MGI:1913955
Chromosome
Chr 17 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000088506
NCBI Transcript ID
NM_025718
Target Region
Exon 2~7
Size of Effective Region
~1.5 kb
Overview of Gene Research
Dnase1l2, or DNase1-like 2, is an endonuclease with metal-dependent endonuclease activity, having a broad pH range with an acidic optimum [2,5]. It plays a crucial role in DNA degradation processes, especially during the terminal differentiation of keratinocytes. This involves the removal of nuclear DNA in the formation of the stratum corneum, hair, nails, and in maintaining innate antimicrobial defense in the epidermis [3,4,8]. It may also be involved in biological processes related to the epithelial-mesenchymal transition [1]. Genetic models, such as knockout mice, have been essential in studying its functions.

In mouse models, inactivation of Dnase1l2 alone or in combination with other nucleases has provided insights into its role. For example, Dnase1l2 -/- mice showed aberrant retention of DNA in hair, nails, tongue, and esophagus epithelia, with the presence of nuclear DNA disturbing the normal arrangement of structural proteins in hair corneocytes and reducing hair's mechanical stress resistance [8]. In Dnase1l2 -/- Dnase2 Δep mice, nuclear DNA was retained in the stratum corneum, leading to parakeratosis, indicating cooperation between Dnase1l2 and Dnase2 in epidermal cornification [6]. Double deficiency of Trex2 and Dnase1l2 led to massive DNA fragment accumulation in the cornified layers of the tongue epithelium without activating inflammatory responses, suggesting their cooperation in lingual keratinocyte cornification [7].

In conclusion, Dnase1l2 is essential for DNA degradation during the terminal differentiation of keratinocytes in various tissues. Studies using gene knockout mouse models have revealed its role in maintaining the normal structure and function of skin appendages, epidermal cornification, and in preventing parakeratosis. Its potential as a carcinogenic marker in breast cancer, as well as its role in cystic fibrosis lung disease treatment and innate antimicrobial defense, highlights its significance in multiple disease areas [1,2,3].

References:
1. Liu, Chang-Rui, Meng, Fan-Hua. 2020. DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process. In Cancer biotherapy & radiopharmaceuticals, 36, 180-188. doi:10.1089/cbr.2019.3504. https://pubmed.ncbi.nlm.nih.gov/32343605/
2. Delfino, Danila, Mori, Giulia, Rivetti, Claudio, Pasut, Gianfranco, Percudani, Riccardo. 2021. Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease. In Biomolecules, 11, . doi:10.3390/biom11030410. https://pubmed.ncbi.nlm.nih.gov/33802146/
3. Eckhart, L, Fischer, H, Barken, K B, Tolker-Nielsen, T, Tschachler, E. 2007. DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. In The British journal of dermatology, 156, 1342-5. doi:. https://pubmed.ncbi.nlm.nih.gov/17459041/
4. Fischer, Heinz, Eckhart, Leopold, Mildner, Michael, Ghannadan, Minoo, Tschachler, Erwin. 2006. DNase1L2 degrades nuclear DNA during corneocyte formation. In The Journal of investigative dermatology, 127, 24-30. doi:. https://pubmed.ncbi.nlm.nih.gov/16902420/
5. Mori, Giulia, Delfino, Danila, Pibiri, Paola, Rivetti, Claudio, Percudani, Riccardo. 2022. Origin and significance of the human DNase repertoire. In Scientific reports, 12, 10364. doi:10.1038/s41598-022-14133-w. https://pubmed.ncbi.nlm.nih.gov/35725583/
6. Fischer, Heinz, Buchberger, Maria, Napirei, Markus, Tschachler, Erwin, Eckhart, Leopold. 2017. Inactivation of DNase1L2 and DNase2 in keratinocytes suppresses DNA degradation during epidermal cornification and results in constitutive parakeratosis. In Scientific reports, 7, 6433. doi:10.1038/s41598-017-06652-8. https://pubmed.ncbi.nlm.nih.gov/28743926/
7. Manils, Joan, Fischer, Heinz, Climent, Joan, Eckhart, Leopold, Soler, Concepció. 2017. Double deficiency of Trex2 and DNase1L2 nucleases leads to accumulation of DNA in lingual cornifying keratinocytes without activating inflammatory responses. In Scientific reports, 7, 11902. doi:10.1038/s41598-017-12308-4. https://pubmed.ncbi.nlm.nih.gov/28928425/
8. Fischer, Heinz, Szabo, Sandra, Scherz, Jennifer, Tschachler, Erwin, Eckhart, Leopold. 2011. Essential role of the keratinocyte-specific endonuclease DNase1L2 in the removal of nuclear DNA from hair and nails. In The Journal of investigative dermatology, 131, 1208-15. doi:10.1038/jid.2011.13. https://pubmed.ncbi.nlm.nih.gov/21307874/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research